CLINICAL EFFICACY OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM IN THE TREATMENT OF PEYRONIE'S DISEASE BY BASELINE PENILE CURVATURE SEVERITY STRATUM: RESULTS FROM TWO LARGE DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 STUDIES

被引：0
|
作者：
Lipshultz, Larry
Gelbard, Martin
Love, Christopher
Smith, Ted
Tursi, James
Kaufman, Gregory
Morgentaler, Abraham
机构：
来源：
JOURNAL OF UROLOGY | 2013年 / 189卷 / 04期
关键词：
D O I：
10.1016/j.juro.2013.02.2584
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1230
引用
收藏
页码：E503 / E504
页数：2
相关论文
共 50 条
  • [21] Disability Severity Category Shift With Fremanezumab Treatment: Pooled Results of 3 Randomized, Double-Blind, Placebo-Controlled Phase 3 Studies
    Nagy, A. J.
    Cohen, J. M.
    Ning, X.
    Ramirez-Campos, V
    Janka, L.
    McAllister, P.
    HEADACHE, 2020, 60 : 11 - 11
  • [22] Inhaled Lidocaine for the Treatment of Asthma: Lack of Efficacy in Two Double-Blind, Randomized, Placebo-Controlled Clinical Studies
    Abuan, Tammy
    Yeager, Melissa
    Montgomery, A. Bruce
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2010, 23 (06) : 381 - 388
  • [23] Commentary on Collagenase Clostridium Histolyticum-Aaes for the Treatment of Cellulite in Women: Results From 2 Phase 3 Randomized, Placebo-Controlled Trials
    Draelos, Zoe Diana
    DERMATOLOGIC SURGERY, 2021, 47 (05) : 657 - 657
  • [24] Liposomal recombinant human superoxide dismutase for the treatment of Peyronie's disease:: A randomized placebo-controlled double-blind clinical study
    Riedl, CR
    Sternig, P
    Langmann, F
    Galle, G
    Engelhardt, PF
    Vcelar, B
    Vorauer, K
    Wagner, A
    Katinger, H
    Pflüger, H
    JOURNAL OF UROLOGY, 2005, 173 (04): : 253 - 254
  • [25] Liposomal recombinant human superoxide dismutase for the treatment of Peyronie's disease: A randomized placebo-controlled double-blind clinical study
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (03) : 219 - 219
  • [26] EFFICACY OF LURASIDONE IN BIPOLAR DEPRESSION: RESULTS FROM TWO DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES
    Pikalov, A.
    Silva, R.
    Cucchiaro, J.
    Sarma, K.
    Hsu, J.
    Loebel, A.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2016, 50 : 132 - 132
  • [27] Onset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine: Integrated Results From 2 Randomized Double-Blind Placebo-Controlled Phase 3 Clinical Studies
    Ashina, Messoud
    Vasudeva, Raghavendra
    Jin, Leah
    Lombard, Louise
    Gray, Elizabeth
    Doty, Erin G.
    Yunes-Medina, Laura
    Kinchen, Kraig S.
    Tassorelli, Cristina
    HEADACHE, 2019, 59 (10): : 1788 - 1801
  • [28] Phase 2a, randomized, double-blind, placebo-controlled dose-ranging study of repeat doses of collagenase clostridium histolyticum for the treatment of edematous fibrosclerotic panniculopathy (cellulite)
    Goldman, Mitchel P.
    Sadick, Neil S.
    Young, Leroy
    Kaufman, Gregory J.
    Smith, Ted
    Tursi, James P.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB19 - AB19
  • [29] Liposomal recombinant human superoxide dismutase for the treatment of Peyronie's disease:: A randomized placebo-controlled double-blind prospective clinical study
    Riedl, CR
    Sternig, P
    Gallé, G
    Langmann, F
    Vcelar, B
    Vorauer, K
    Wagner, A
    Katinger, H
    Pflüger, H
    EUROPEAN UROLOGY, 2005, 48 (04) : 656 - 661
  • [30] Favipiravir Treatment of Uncomplicated Influenza in Adults: Results of Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Trials
    Hayden, Frederick G.
    Lenk, Robert P.
    Stonis, Lucille
    Oldham-Creamer, Catherine
    Kang, Lih Lisa
    Epstein, Carol
    JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (10): : 1790 - 1799
12345